Lv41
620 积分 2022-06-07 加入
Relapses during treatment with monoclonal antibodies targeting B-cells in NMOSD
8天前
已完结
Prognostic Factors for Multiple Sclerosis Symptoms in Radiologically Isolated Syndrome
14天前
已完结
Standardized Definition of Progression Independent of Relapse Activity (PIRA) in Relapsing-Remitting Multiple Sclerosis
16天前
已完结
Analysis of infection rates in neuromyelitis optica spectrum disorder: Comparing satralizumab treatment in SAkuraMoon, post-marketing, and US-based health claims data
19天前
已完结
Analysis of infection rates in neuromyelitis optica spectrum disorder: Comparing satralizumab treatment in SAkuraMoon, post-marketing, and US-based health claims data
27天前
已完结
Ponesimod Compared With Teriflunomide in Patients With Relapsing Multiple Sclerosis in the Active-Comparator Phase 3 OPTIMUM Study
27天前
已完结
Prevalence of 2-year “No evidence of disease activity” (NEDA-3 and NEDA-4) in relapsing-remitting multiple sclerosis. A real-world study
28天前
已完结
Safety and efficacy of gene therapy with onasemnogene abeparvovec in the treatment of spinal muscular atrophy: A systematic review and meta‐analysis
28天前
已完结
Efficacy of risdiplam in spinal muscular atrophy: A systematic review and meta‐analysis
28天前
已完结
Faster and better than a physician?: Assessing diagnostic proficiency of ChatGPT in misdiagnosed individuals with neuromyelitis optica spectrum disorder
1个月前
已完结
皖公网安备34019202002308
